Additional safeguards that may be included in a social and behavioral study may include:

The answer

In a social and behavioral (SBE) study, additional safeguards are extra measures — beyond baseline consent — that protect subjects from the harms most likely in this kind of research. The correct answer set typically includes:

• Removing direct identifiers as soon as possible (names, addresses, Social Security numbers, contact details) so data can't be traced back to individuals.
• Collecting data anonymously where feasible, so identifiers are never attached in the first place.
• Monitoring the data being collected to ensure ongoing subject safety and confidentiality, and to catch problems early.

These target the defining feature of SBE research: the primary risks are usually not physical injury but breaches of confidentiality and the resulting psychological, social, economic, or legal harms (embarrassment, stigma, loss of employment or insurability, legal jeopardy).

Why these safeguards fit the risk

Social and behavioral studies collect sensitive information — about mental health, sexual behavior, drug use, immigration status, finances, or illegal activity. If that information leaked and were linked to a named person, the person could be harmed even though nothing physically happened to them during the study. So the safeguards are aimed squarely at de-identification and information security:

• Stripping identifiers early shrinks the window during which a leak could expose someone.
• Anonymous collection removes the link entirely, which is the strongest protection.
• Monitoring provides oversight so that emerging risks (a flawed instrument, an unexpectedly sensitive response pattern, a data-handling gap) are addressed before harm occurs.

Other valid SBE safeguards you may see include coding data and storing the key separately, using Certificates of Confidentiality to resist forced disclosure, limiting who can access the data, and secure/encrypted storage.

Why the distractors are wrong

CITI-style distractors usually list measures borrowed from biomedical research that don't map to SBE risk:

• "A Data Safety Monitoring Board (DSMB)" — a formal DSMB is characteristic of clinical trials with physical/medical endpoints, not the typical safeguard for a survey or interview study.
• "Emergency medical care / rescue medication on standby" — appropriate for drug or device trials, irrelevant to most behavioral research where physical harm isn't the concern.
• "Randomization or a placebo control" — these are study-design choices, not confidentiality safeguards.

Remember the core distinction: anonymous means identifiers are never collected, so even the researcher can't link responses to a person; confidential means identifiers exist but are protected and not disclosed. Choosing safeguards well means matching them to the SBE harm — protecting information — rather than importing physical-safety machinery from clinical trials.